Medtronic to bring Endeavor to China

Interventional technology firm Medtronic has received regulatory approval from the government of the People's Republic of China for its Endeavor drug-eluting coronary stent system.

Endeavor is now commercially available in approximately 100 countries, according to the Minneapolis-based firm. Medtronic said it remains on track to complete the premarket approval (PMA) process for Endeavor in the U.S. in 2007.

By AuntMinnie.com staff writers
June 21, 2006

Related Reading

Medtronic nets French reimbursement approval, June 12, 2006

Stereotaxis, Medtronic partner for clinical study, May 18, 2006

Medtronic gets nod for Micro-Driver, May 1, 2006

Medtronic sues Kyphon, April 17, 2006

Medtronic gets FDA nod for AAA stent system, March 28, 2006

Copyright © 2006 AuntMinnie.com

Page 1 of 180
Next Page